Minimal potency loss of reconstituted yellow fever vaccine over six hours: Implications for fractional-dose vaccination
Clicks: 27
ID: 322480
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
7.8
/100
27 views
10 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #16 of 57 articles by views in international journal of travel medicine and global health
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Nirupama A Nammunige, PhD, Deborah J Mills, MBBS MPHTM, Leon E Hugo, PhD, Luis Furuya-Kanamori, MBBS PhD; Minimal potency loss of reconstituted yellow feve
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (24 words).
Try re-searching for a better abstract.
| Reference Key |
openalex_W7170148874
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Nirupama A Nammunige, Deborah J Mills, Leon E. Hugo, Luis Furuya-Kanamori |
| Journal | international journal of travel medicine and global health |
| Year | 2026 |
| DOI |
10.1093/jtm/taag069
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.